English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 25 May 2021, 18:00 HKT/SGT

Source: Genesis MedTech Group
Genesis Medtech Group Raises Significant Growth Investment in Latest Round of Series B Financing

SINGAPORE, May 25, 2021 - (ACN Newswire) - Genesis MedTech Group ("Genesis"), a leading medical device company, today announced it has completed its Series B round, raising significant growth financing. General Atlantic, a leading global growth equity firm, led the funding with participation from CITIC Capital and others. The majority of shareholders from Series A followed up with additional investments. Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, will join the Genesis Board of Directors.

The funds will be used to drive the research and development of new products and the commercialization of existing products, as well as enable business expansion in emerging markets around the world. This acceleration in Genesis' model is expected to enable patients and healthcare practitioners in emerging markets to access innovative medtech products that can address unmet needs faced day-to-day -- Genesis' mission since its inception in 2019.

Meeting Needs Where They Are

Genesis' purpose was born to solve a growing healthcare issue within emerging markets, where increased health problems and demand for medtech solutions are not proportionally addressed by accessible products currently on the market. Despite rapid developments in medtech innovation globally, many of these products remain out of reach for patients and practitioners in these markets.

Genesis seeks to address this issue and has received significant support from innovators worldwide. Its vertically integrated business model, complete with a wide hospital and clinic network, allows for a deep understanding of patients' and practitioners' needs on the ground. Armed with this knowledge, Genesis collaborates with innovators worldwide through an open medtech platform that accelerates meaningful innovations that are cost-effective to meet healthcare needs in these markets.

Warren Wang, Chairman and CEO of Genesis Medtech Group, outlined the importance of collaboration with leading global partners and putting market needs first and foremost: "Our open platform is quintessential in enabling us to bring the world's leading products and technologies to doctors and patients. We will also invest in adding premier talent, consolidating our R&D capabilities, incubating new technologies, and continuing to pursue solutions that answer the real needs of patients and healthcare practitioners -- delivering impact where it is needed most."

Lefei Sun, Managing Director and Head of Healthcare for China at General Atlantic, added, "We are excited to help propel the work that Genesis is doing to advance access to healthcare and innovative medical solutions in emerging markets. We believe Genesis' capability set is highly differentiated through the combination of its technology, product and team, with a comprehensive portfolio underpinned by a scalable and integrated platform. This latest round of funding will enable Genesis to continue to tackle disparities in medtech accessibility across global markets. We look forward to partnering with Genesis in this next chapter of its growth."

To date, Genesis' product portfolio includes surgical, neurovascular, peripheral vascular and cardiovascular products. Genesis collaborated with medtech leaders in bringing multiple innovations into China as part of its commitment to making quality healthcare more affordable and accessible for emerging markets.


Genesis MedTech Group is a medical device company headquartered in Singapore. Founded by a group of professionals and entrepreneurs with MedTech experience globally and in Asia, the company's product portfolio focuses on value segment multi-therapy medical device products for emerging markets with sales and distribution through its established commercial network. Genesis MedTech Group covers the entire industry value chain of research and development, production, quality management, supply chain, marketing, and sales.
For more information, visit http://www.genesismedtech.com.


General Atlantic is a leading global growth equity firm providing capital and strategic support for growth companies. Established in 1980, General Atlantic combines a collaborative global approach, sector specific expertise, a long-term investment horizon and a deep understanding of growth drivers to partner with great entrepreneurs and management teams to build market-leading businesses worldwide. General Atlantic has more than 175 investment professionals based in New York, Amsterdam, Beijing, Greenwich, Hong Kong, Jakarta, London, Mexico City, Mumbai, Munich, Palo Alto, Sao Paulo, Shanghai and Singapore. For more information on General Atlantic, please visit the website: www.generalatlantic.com.

For media queries, please contact:

In Singapore:
Karen Chng, Genesis MedTech Group
DID: +65 6865 9879, Email: karen.chng@gmedtech.com

Tracy Huang, Senior Manager, PR and Comms, Genesis MedTech Group
DID: +86 13764630248, Email: tracy.huang@gmedtech.com

Genesis MedTech Group
16 Science Park Drive, #04-03, DNV GL Technology Centre, Singapore 118227
Main Line: +65 68659879, Online: https://www.genesismedtech.com

Topic: Press release summary
Source: Genesis MedTech Group

Sectors: MedTech
From the Asia Corporate News Network

Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Latest Press Releases
Scout Gaming the Leading Provider of B2B Daily Fantasy Sports Enters US Market via Partnership with SCCG.  
Sept 18, 2021 00:09 HKT/SGT
World's Top Universities Look to Scale a Certified Blockchain Workforce  
Sept 17, 2021 23:31 HKT/SGT
Massive NFT and Token Giveaway from Polker as Staking is Announced  
Sept 17, 2021 19:00 HKT/SGT
Shareschart Launches Its Online Proprietary Stock Analysis Software  
Sept 17, 2021 19:00 HKT/SGT
TVS Motor Company Forays Into the Personal E-Mobility Business With a Majority Stake in European E-Bike Brand EGO Movement  
Sept 17, 2021 18:14 HKT/SGT
Ni Hsin Signs MoU with Tailg for Electric Vehicles Collaboration  
Sept 17, 2021 14:00 HKT/SGT
FULONGMA heralds Thailand's EV sanitation equipment breakthrough  
Sept 17, 2021 11:34 HKT/SGT
SinoMab, Sinovent and Everest Medicines Announce Licensing Agreement for Global Development and Commercialization of A Next-Generation BTK Inhibitor in Renal Diseases  
Sept 17, 2021 08:40 HKT/SGT
UREEQA Announces New Qards Campaign, Staking Pools and Tier Structure  
Sept 16, 2021 21:00 HKT/SGT
Honda Exhibits the World Premiere of All-new BF150, BF135 and BF115 Large-size Marine Outboard Engines at the Genoa International Boat Show 2021  
Sept 16, 2021 18:08 HKT/SGT
More Press release >>
More events >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575